首页> 外文期刊>Oncology Research >DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells
【24h】

DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells

机译:DKK3过表达增加了头部和颈部鳞状细胞癌细胞的恶性性质

获取原文
获取原文并翻译 | 示例
       

摘要

DKK3, a member of the dickkopf Wnt signaling pathway inhibitor family, is believed to be a tumor suppressor because of its reduced expression in cancer cells. However, our previous studies have revealed that DKK3 expression is predominantly observed in head and neck/oral squamous cell carcinoma (HNSCC/OSCC). Interestingly, HNSCC/OSCC patients with DKK3 expression showed a high rate of metastasis and poorer survival, and siRNA-mediated knockdown of DKK3 in HNSCC-derived cancer cell lines resulted in reduced cellular migration and invasion. From these data, it was hypothesized that DKK3 might exert an oncogenic function specific to HNSCC. In the present research, the DKK3 overexpression model was established, and its influences were investigated, together with molecular mechanism studies. The DKK3 expression profile in cancer cell lines was investigated, including HNSCC/OSCC, esophageal, gastric, colorectal, pancreatic, prostatic, and lung cancers. DKK3 overexpression was performed in HNSCC-derived cells by transfection of expression plasmid. The effects of DKK3 overexpression were assessed on cellular proliferation, migration, invasion, and in vivo tumor growth. The molecular mechanism of DKK3 overexpression was investigated by Western blotting and microarray analysis. DKK3 overexpression significantly elevated cellular proliferation, migration, and invasion, as well as increased mRNA expression of cyclin D1 and c-myc. However, reporter assays did not show TCF/LEF activation, suggesting that the increased malignant property of cancer cells was not driven by the Wnt/beta-catenin pathway. For the investigation of the pathways/molecules in DKK3-mediated signals, the Western blot analyses revealed that phosphorylation of Akt (S473) and c-Jun (Ser63) was elevated. The application of a PI3K kinase inhibitor, LY294002, on HSC-3 DKK3 cells significantly decreased tumor cell proliferation, migration, and invasion. From these results, we demonstrated that DKK3 might contribute to cellular proliferation, invasion, migration, and tumor cell survival in HNSCC cells through a mechanism other than the canonical Wnt signaling pathway, which might be attributed to PI3K-Akt signaling.
机译:DKK3是Dickkopf Wnt信号传导途径抑制剂家族的成员,被认为是肿瘤抑制因素,因为它在癌细胞中的表达降低。然而,我们以前的研究表明,在头部和颈部/口腔鳞状细胞癌(HNSCC / OSCC)中主要观察到DKK3表达。有趣的是,HNSCC / OSCC患者DKK3表达显示出高速率和较差的存活率,并且SiRNA介导的DKK3在HNSCC衍生的癌细胞系中导致细胞迁移和侵袭降低。从这些数据中,假设DKK3可能发挥特定于HNSCC的致癌功能。在本研究中,建立了DKK3过表达模型,并研究了其影响,以及分子机制研究。研究了癌细胞系中的DKK3表达谱,包括HNSCC / OSCC,食管,胃,结直肠癌,胰腺,前列腺和肺癌。通过对表达质粒转染在HNSCC衍生的细胞中进行DKK3过表达。对细胞增殖,迁移,侵袭和体内肿瘤生长评估DKK3过表达的影响。通过Western印迹和微阵列分析研究了DKK3过表达的分子机制。 DKK3过表达的细胞增殖,迁移和侵袭显着升高,以及Cyclin D1和C-Myc的mRNA表达增加。然而,记者测定没有显示TCF / LEF激活,表明癌细胞的恶性性质增加未被WNT /β-连环蛋白途径驱动。为了调查DKK3介导的信号中的途径/分子,蛋白质印迹分析显示AKT(S473)和C-JUM(SER63)的磷酸化升高。 PI3K激酶抑制剂LY294002在HSC-3 DKK3细胞上的应用显着降低了肿瘤细胞增殖,迁移和侵袭。从这些结果中,我们证明DKK3可以通过除规范WNT信号传导途径之外的机制有助于HNSCC细胞中的细胞增殖,侵袭,迁移和肿瘤细胞存活,这可能归因于PI3K-AKT信号传导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号